US Heart Health Progress Stalls
New US cardiovascular statistics document persistent gaps in prevention and treatment across hypertension, diabetes, obesity, and cholesterol management, with marked disparities by age, income, and race.
By
Kathryn Wighton
January 14, 2026
Clinical Scorecard: US Heart Health Progress Stalls
At a Glance
Category Detail
Condition Hypertension, diabetes, obesity, dyslipidemia Key Mechanisms Limited improvement in treatment and control over 15 years Target Population US adults, particularly men and Black adults Care Setting Primary care and specialty cardiovascular clinics
Key Highlights
Nearly 50% of US adults meet criteria for hypertension under current guidelines Obesity prevalence has risen to over 40% among adults Diabetes prevalence increased from 12% to 14% between 2009 and 2023 Hypertension-related cardiovascular mortality nearly doubled from 2000 to 2019 Disparities in cardiovascular risk factors persist by race, income, geography, and age Guideline-Based Recommendations
Diagnosis
Use contemporary clinical definitions for hypertension and diabetes Management
Increase treatment rates for hypertension and diabetes Expand access to bariatric surgery and anti-obesity pharmacotherapy Monitoring & Follow-up
Regularly assess blood pressure and glycemic control in patients Risks
Monitor for increased cardiovascular mortality related to hypertension and diabetes Patient & Prescribing Data
Adults with hypertension, diabetes, and obesity
Only two-thirds of adults with hypertension receive treatment; glycemic control in diabetes is achieved by about half of patients
Clinical Best Practices
Implement routine screening for hypertension and diabetes Encourage lifestyle modifications alongside pharmacotherapy Address social determinants of health to reduce disparities References
